Microba Life Sciences Ltd (ASX:MAP) has debuted on the ASX following IPO raising $30m

Microba Life Sciences Ltd (ASX:MAP) has debuted on the Australian stock exchange today.

Following an IPO at $0.45/share raising $30 million, shares in the precision microbiome science medical innovation company fell 24.45% to close its debut session at $0.34/share.

An increase in listing price is a vote of confidence from the market about the future prospects of the company.

A decrease in the listing price can be interpreted in a number of ways, including whether the IPO was accurately priced.